Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric R Bates

Showing results (11-20 of 234) with videos related to

Pageof 24
Sort By:
JACC. Cardiovascular Interventions|November 4, 2019
Achieving Aspirational Goals in Providing Primary Percutaneous Coronary Intervention CareEric R Bates
JACC. Case Reports|July 28, 2021
Requiem by a Member of the Inaugural Generation of Interventional CardiologistsEric R Bates
JACC. Case Reports|July 28, 2021
Did "Pistol" Pete Maravich Die From Congenital Coronary Artery Disease or Acquired Myocardial Disease?Eric R Bates
Annals of Internal Medicine|August 18, 2020
Invasive therapy improved angina health status in patients with high-risk stable coronary disease and more frequent anginaEric R Bates
Annals of Internal Medicine|August 18, 2020
In stable coronary disease with moderate or severe ischemia, initial invasive therapy plus medical therapy did not improve CV outcomes at 3 yearsEric R Bates
ACP Journal Club|August 20, 2008
Review: limited evidence suggests that statins are safe in patients with liver diseaseEric R Bates
Trends in Cardiovascular Medicine|October 17, 2017
MY APPROACH to the patient with left main diseaseEric R Bates
Annals of Internal Medicine|March 15, 2016
Review: In patients with chest pain, risk scores better predict high risk for ACS than individual risk factorsEric R Bates
Journal of the American College of Cardiology|January 3, 2024
Clinically Significant Differences Between P2Y<sub>12</sub> Inhibitor Monotherapy and Aspirin Monotherapy Have Yet to Be DemonstratedEric R Bates
Annals of Internal Medicine|December 1, 2025
P2Y12 inhibitor monotherapy soon after PCI for ACS was not noninferior to DAPT for a composite of death or ischemic eventsEric R Bates,
Pageof 24

Showing results (11-20 of 234) with videos related to

Sort By:
Pageof 24
JACC. Cardiovascular Interventions|November 4, 2019
Achieving Aspirational Goals in Providing Primary Percutaneous Coronary Intervention CareEric R Bates
JACC. Case Reports|July 28, 2021
Requiem by a Member of the Inaugural Generation of Interventional CardiologistsEric R Bates
JACC. Case Reports|July 28, 2021
Did "Pistol" Pete Maravich Die From Congenital Coronary Artery Disease or Acquired Myocardial Disease?Eric R Bates
Annals of Internal Medicine|August 18, 2020
Invasive therapy improved angina health status in patients with high-risk stable coronary disease and more frequent anginaEric R Bates
Annals of Internal Medicine|August 18, 2020
In stable coronary disease with moderate or severe ischemia, initial invasive therapy plus medical therapy did not improve CV outcomes at 3 yearsEric R Bates
ACP Journal Club|August 20, 2008
Review: limited evidence suggests that statins are safe in patients with liver diseaseEric R Bates
Trends in Cardiovascular Medicine|October 17, 2017
MY APPROACH to the patient with left main diseaseEric R Bates
Annals of Internal Medicine|March 15, 2016
Review: In patients with chest pain, risk scores better predict high risk for ACS than individual risk factorsEric R Bates
Journal of the American College of Cardiology|January 3, 2024
Clinically Significant Differences Between P2Y<sub>12</sub> Inhibitor Monotherapy and Aspirin Monotherapy Have Yet to Be DemonstratedEric R Bates
Annals of Internal Medicine|December 1, 2025
P2Y12 inhibitor monotherapy soon after PCI for ACS was not noninferior to DAPT for a composite of death or ischemic eventsEric R Bates,
Pageof 24